市場調查報告書
商品編碼
997456

攝生學(健康生活學)的全球市場

Eubiotics

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 278 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球攝生學(健康生活學)的市場規模,預計在分析期間(2020年∼2027年)將以6.1%的年複合成長率增長,從2020年的58億美元,到2027年達到89億美元。

本報告所分析的市場區隔之一的益生菌部門,在分析期間中預計將以6.7%的年複合成長率增長,達到35億美元。

本報告提供全球攝生學(健康生活學)市場的相關調查,提供市場佔有率,Covid-19的影響,趨勢和成長要素,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

調查對象企業範例

  • ADDCON GmbH
  • Advanced BioNutrition Corporation
  • BASF SE
  • Behn Meyer Holding AG
  • BENEO GmbH
  • Calpis Co., Ltd.
  • Cargill, Inc.
  • Chr. Hansen Holding A/S
  • DowDuPont, Inc.
  • Kemin Industries, Inc.
  • Koninklijke DSM NV
  • Lallemand, Inc.
  • Lesaffre Group
  • Novozymes A/S
  • Novus International, Inc.

目錄

I. 調查手法

II. 摘要整理

  • 市場概要
    • 影響者市場洞察
    • 全球市場的軌跡
    • Covid-19的影響與即將到來的全球景氣衰退
  • 主要企業
  • 趨勢與推動要素
  • 全球市場預測

III. 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 其他地區

IV. 競爭

  • 企業簡介:41公司
目錄
Product Code: MCP11869

Abstract:

Global Eubiotics Market to Reach $8.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Eubiotics estimated at US$5.8 Billion in the year 2020, is projected to reach a revised size of US$8.9 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027. Probiotics, one of the segments analyzed in the report, is projected to record a 6.7% CAGR and reach US$3.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Prebiotics segment is readjusted to a revised 5.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.7 Billion, While China is Forecast to Grow at 5.7% CAGR

The Eubiotics market in the U.S. is estimated at US$1.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 5.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.

Organic Acids Segment to Record 6.2% CAGR

In the global Organic Acids segment, USA, Canada, Japan, China and Europe will drive the 6.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.3 Billion in the year 2020 will reach a projected size of US$2.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1 Billion by the year 2027.

Select Competitors (Total 41 Featured) -

  • ADDCON GmbH
  • Advanced BioNutrition Corporation
  • BASF SE
  • Behn Meyer Holding AG
  • BENEO GmbH
  • Calpis Co., Ltd.
  • Cargill, Inc.
  • Chr. Hansen Holding A/S
  • DowDuPont, Inc.
  • Kemin Industries, Inc.
  • Koninklijke DSM NV
  • Lallemand, Inc.
  • Lesaffre Group
  • Novozymes A/S
  • Novus International, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Eubiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Eubiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Eubiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Probiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Prebiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Prebiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Prebiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Organic Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Organic Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Organic Acids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Essential Oils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Essential Oils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Essential Oils by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Swine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Swine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Swine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Poultry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Poultry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Poultry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Other Livestocks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Other Livestocks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Other Livestocks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Ruminants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Ruminants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Ruminants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Dry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Dry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Dry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 32: World Historic Review for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: World 15-Year Perspective for Liquid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 34: World Current & Future Analysis for Nutrition & Gut Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 35: World Historic Review for Nutrition & Gut Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: World 15-Year Perspective for Nutrition & Gut Health by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 37: World Current & Future Analysis for Yield by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 38: World Historic Review for Yield by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: World 15-Year Perspective for Yield by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 40: World Current & Future Analysis for Immunity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 41: World Historic Review for Immunity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: World 15-Year Perspective for Immunity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 43: World Current & Future Analysis for Other Functions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 44: World Historic Review for Other Functions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: World 15-Year Perspective for Other Functions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 46: USA Current & Future Analysis for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: USA Historic Review for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: USA 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Organic Acids and Essential Oils for the Years 2012, 2020 & 2027
    • TABLE 49: USA Current & Future Analysis for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: USA Historic Review for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: USA 15-Year Perspective for Eubiotics by Livestock - Percentage Breakdown of Value Sales for Swine, Poultry, Other Livestocks and Ruminants for the Years 2012, 2020 & 2027
    • TABLE 52: USA Current & Future Analysis for Eubiotics by Form - Dry and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 53: USA Historic Review for Eubiotics by Form - Dry and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: USA 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Dry and Liquid for the Years 2012, 2020 & 2027
    • TABLE 55: USA Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: USA Historic Review for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: USA 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Yield, Immunity and Other Functions for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 58: Canada Current & Future Analysis for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Canada Historic Review for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: Canada 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Organic Acids and Essential Oils for the Years 2012, 2020 & 2027
    • TABLE 61: Canada Current & Future Analysis for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Canada Historic Review for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: Canada 15-Year Perspective for Eubiotics by Livestock - Percentage Breakdown of Value Sales for Swine, Poultry, Other Livestocks and Ruminants for the Years 2012, 2020 & 2027
    • TABLE 64: Canada Current & Future Analysis for Eubiotics by Form - Dry and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Canada Historic Review for Eubiotics by Form - Dry and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: Canada 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Dry and Liquid for the Years 2012, 2020 & 2027
    • TABLE 67: Canada Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Canada Historic Review for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: Canada 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Yield, Immunity and Other Functions for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 70: Japan Current & Future Analysis for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Japan Historic Review for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: Japan 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Organic Acids and Essential Oils for the Years 2012, 2020 & 2027
    • TABLE 73: Japan Current & Future Analysis for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Japan Historic Review for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: Japan 15-Year Perspective for Eubiotics by Livestock - Percentage Breakdown of Value Sales for Swine, Poultry, Other Livestocks and Ruminants for the Years 2012, 2020 & 2027
    • TABLE 76: Japan Current & Future Analysis for Eubiotics by Form - Dry and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Japan Historic Review for Eubiotics by Form - Dry and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: Japan 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Dry and Liquid for the Years 2012, 2020 & 2027
    • TABLE 79: Japan Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Japan Historic Review for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: Japan 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Yield, Immunity and Other Functions for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 82: China Current & Future Analysis for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 83: China Historic Review for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: China 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Organic Acids and Essential Oils for the Years 2012, 2020 & 2027
    • TABLE 85: China Current & Future Analysis for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: China Historic Review for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: China 15-Year Perspective for Eubiotics by Livestock - Percentage Breakdown of Value Sales for Swine, Poultry, Other Livestocks and Ruminants for the Years 2012, 2020 & 2027
    • TABLE 88: China Current & Future Analysis for Eubiotics by Form - Dry and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 89: China Historic Review for Eubiotics by Form - Dry and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: China 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Dry and Liquid for the Years 2012, 2020 & 2027
    • TABLE 91: China Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: China Historic Review for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: China 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Yield, Immunity and Other Functions for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 94: Europe Current & Future Analysis for Eubiotics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 95: Europe Historic Review for Eubiotics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 96: Europe 15-Year Perspective for Eubiotics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 97: Europe Current & Future Analysis for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Europe Historic Review for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 99: Europe 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Organic Acids and Essential Oils for the Years 2012, 2020 & 2027
    • TABLE 100: Europe Current & Future Analysis for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Europe Historic Review for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 102: Europe 15-Year Perspective for Eubiotics by Livestock - Percentage Breakdown of Value Sales for Swine, Poultry, Other Livestocks and Ruminants for the Years 2012, 2020 & 2027
    • TABLE 103: Europe Current & Future Analysis for Eubiotics by Form - Dry and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Europe Historic Review for Eubiotics by Form - Dry and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 105: Europe 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Dry and Liquid for the Years 2012, 2020 & 2027
    • TABLE 106: Europe Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Europe Historic Review for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 108: Europe 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Yield, Immunity and Other Functions for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 109: France Current & Future Analysis for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 110: France Historic Review for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 111: France 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Organic Acids and Essential Oils for the Years 2012, 2020 & 2027
    • TABLE 112: France Current & Future Analysis for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 113: France Historic Review for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 114: France 15-Year Perspective for Eubiotics by Livestock - Percentage Breakdown of Value Sales for Swine, Poultry, Other Livestocks and Ruminants for the Years 2012, 2020 & 2027
    • TABLE 115: France Current & Future Analysis for Eubiotics by Form - Dry and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 116: France Historic Review for Eubiotics by Form - Dry and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 117: France 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Dry and Liquid for the Years 2012, 2020 & 2027
    • TABLE 118: France Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 119: France Historic Review for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 120: France 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Yield, Immunity and Other Functions for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 121: Germany Current & Future Analysis for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Germany Historic Review for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 123: Germany 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Organic Acids and Essential Oils for the Years 2012, 2020 & 2027
    • TABLE 124: Germany Current & Future Analysis for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Germany Historic Review for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 126: Germany 15-Year Perspective for Eubiotics by Livestock - Percentage Breakdown of Value Sales for Swine, Poultry, Other Livestocks and Ruminants for the Years 2012, 2020 & 2027
    • TABLE 127: Germany Current & Future Analysis for Eubiotics by Form - Dry and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Germany Historic Review for Eubiotics by Form - Dry and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 129: Germany 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Dry and Liquid for the Years 2012, 2020 & 2027
    • TABLE 130: Germany Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Germany Historic Review for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 132: Germany 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Yield, Immunity and Other Functions for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 133: Italy Current & Future Analysis for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Italy Historic Review for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 135: Italy 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Organic Acids and Essential Oils for the Years 2012, 2020 & 2027
    • TABLE 136: Italy Current & Future Analysis for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Italy Historic Review for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 138: Italy 15-Year Perspective for Eubiotics by Livestock - Percentage Breakdown of Value Sales for Swine, Poultry, Other Livestocks and Ruminants for the Years 2012, 2020 & 2027
    • TABLE 139: Italy Current & Future Analysis for Eubiotics by Form - Dry and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Italy Historic Review for Eubiotics by Form - Dry and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 141: Italy 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Dry and Liquid for the Years 2012, 2020 & 2027
    • TABLE 142: Italy Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Italy Historic Review for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 144: Italy 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Yield, Immunity and Other Functions for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 145: UK Current & Future Analysis for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 146: UK Historic Review for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 147: UK 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Organic Acids and Essential Oils for the Years 2012, 2020 & 2027
    • TABLE 148: UK Current & Future Analysis for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 149: UK Historic Review for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 150: UK 15-Year Perspective for Eubiotics by Livestock - Percentage Breakdown of Value Sales for Swine, Poultry, Other Livestocks and Ruminants for the Years 2012, 2020 & 2027
    • TABLE 151: UK Current & Future Analysis for Eubiotics by Form - Dry and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 152: UK Historic Review for Eubiotics by Form - Dry and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 153: UK 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Dry and Liquid for the Years 2012, 2020 & 2027
    • TABLE 154: UK Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 155: UK Historic Review for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 156: UK 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Yield, Immunity and Other Functions for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 157: Rest of Europe Current & Future Analysis for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Rest of Europe Historic Review for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 159: Rest of Europe 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Organic Acids and Essential Oils for the Years 2012, 2020 & 2027
    • TABLE 160: Rest of Europe Current & Future Analysis for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Rest of Europe Historic Review for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 162: Rest of Europe 15-Year Perspective for Eubiotics by Livestock - Percentage Breakdown of Value Sales for Swine, Poultry, Other Livestocks and Ruminants for the Years 2012, 2020 & 2027
    • TABLE 163: Rest of Europe Current & Future Analysis for Eubiotics by Form - Dry and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 164: Rest of Europe Historic Review for Eubiotics by Form - Dry and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 165: Rest of Europe 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Dry and Liquid for the Years 2012, 2020 & 2027
    • TABLE 166: Rest of Europe Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 167: Rest of Europe Historic Review for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 168: Rest of Europe 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Yield, Immunity and Other Functions for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 169: Asia-Pacific Current & Future Analysis for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 170: Asia-Pacific Historic Review for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 171: Asia-Pacific 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Organic Acids and Essential Oils for the Years 2012, 2020 & 2027
    • TABLE 172: Asia-Pacific Current & Future Analysis for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 173: Asia-Pacific Historic Review for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 174: Asia-Pacific 15-Year Perspective for Eubiotics by Livestock - Percentage Breakdown of Value Sales for Swine, Poultry, Other Livestocks and Ruminants for the Years 2012, 2020 & 2027
    • TABLE 175: Asia-Pacific Current & Future Analysis for Eubiotics by Form - Dry and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 176: Asia-Pacific Historic Review for Eubiotics by Form - Dry and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 177: Asia-Pacific 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Dry and Liquid for the Years 2012, 2020 & 2027
    • TABLE 178: Asia-Pacific Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 179: Asia-Pacific Historic Review for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 180: Asia-Pacific 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Yield, Immunity and Other Functions for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 181: Rest of World Current & Future Analysis for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Rest of World Historic Review for Eubiotics by Type - Probiotics, Prebiotics, Organic Acids and Essential Oils Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 183: Rest of World 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Organic Acids and Essential Oils for the Years 2012, 2020 & 2027
    • TABLE 184: Rest of World Current & Future Analysis for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Rest of World Historic Review for Eubiotics by Livestock - Swine, Poultry, Other Livestocks and Ruminants Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 186: Rest of World 15-Year Perspective for Eubiotics by Livestock - Percentage Breakdown of Value Sales for Swine, Poultry, Other Livestocks and Ruminants for the Years 2012, 2020 & 2027
    • TABLE 187: Rest of World Current & Future Analysis for Eubiotics by Form - Dry and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Rest of World Historic Review for Eubiotics by Form - Dry and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 189: Rest of World 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Dry and Liquid for the Years 2012, 2020 & 2027
    • TABLE 190: Rest of World Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Rest of World Historic Review for Eubiotics by Function - Nutrition & Gut Health, Yield, Immunity and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 192: Rest of World 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Yield, Immunity and Other Functions for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 41